Anti-VIRMA/KIAA1429 antibody [EPR24279-23] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal VIRMA/KIAA1429 antibody. Carrier free. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse, Human samples.
View Alternative Names
KIAA1429, MSTP054, VIRMA, Protein virilizer homolog
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] - BSA and Azide free (AB289728)
This data was developed using ab271136, the same antibody in a different formulation.
Flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling VIRMA/KIAA1429 with ab271136 at 1/50 dilution (red) compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] - BSA and Azide free (AB289728)
This data was developed using ab271136, the same antibody in a different formulation.
Flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized C2C12 (Mouse myoblasts myoblast) cells labeling VIRMA/KIAA1429 with ab271136 at 1/50 dilution (red) compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] - BSA and Azide free (AB289728)
This data was developed using ab271136, the same antibody clone in a different buffer formulation.
The observed MW are consistent with what has been described in the literature (PMID : 34490238).
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] (<a href='/en-us/products/primary-antibodies/virma-kiaa1429-antibody-epr24279-23-ab271136'>ab271136</a>) at 1/1000 dilution
Lane 1:
PC-3 (human prostate adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
SK-OV-3 (human ovarian cancer epithelial cell), whole cell lysate at 20 µg
Lane 3:
T-47D (human ductal breast epithelial tumor epithelial cell), whole cell lysate at 20 µg
Lane 4:
C2C12 (mouse myoblasts), whole cell lysate at 20 µg
Lane 5:
Mouse liver cancer lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 202 kDa
Observed band size: 202 kDa
false
Exposure time: 26s
- WB
Supplier Data
Western blot - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] - BSA and Azide free (AB289728)
This data was developed using ab271136, the same antibody clone in a different buffer formulation.
Lysates should be made freshly and used in WB immediately to minimize protein degradation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] (<a href='/en-us/products/primary-antibodies/virma-kiaa1429-antibody-epr24279-23-ab271136'>ab271136</a>) at 1/1000 dilution
Lane 1:
HeLa transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with GATA-2 siRNA 1 whole cell lysate at 20 µg
Lane 3:
HeLa transfected with GATA-2 siRNA 2 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 202 kDa
Observed band size: 202 kDa
false
Exposure time: 59s
- WB
Supplier Data
Western blot - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] - BSA and Azide free (AB289728)
This data was developed using ab271136, the same antibody clone in a different buffer formulation.
Lysates should be made freshly and used in WB immediately to minimize protein degradation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-VIRMA/KIAA1429 antibody [EPR24279-23] (<a href='/en-us/products/primary-antibodies/virma-kiaa1429-antibody-epr24279-23-ab271136'>ab271136</a>) at 1/1000 dilution
Lane 1:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 202 kDa
Observed band size: 202 kDa
false
Exposure time: 26s
Related conjugates and formulations (1)
-
Anti-VIRMA/KIAA1429 antibody [EPR24279-23]
Reactivity data
Product details
ab289728 is the carrier-free version of ab271136.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein plays a significant part in mRNA modification by acting as an important component of the m6A writer complex. It contributes to the regulation of gene expression by modulating mRNA stability and translation. The m6A writer complex which includes METTL3 METTL14 and WTAP often coordinates with VIRMA to ensure proper mRNA methylation affecting cellular processes such as differentiation and proliferation. Its involvement in this complex implies its importance for mRNA metabolism and gene expression regulation.
Pathways
VIRMA significantly impacts the RNA processing and degradation pathways. Within these pathways it interacts with proteins such as METTL3 and METTL14 to influence mRNA splicing and degradation which are vital for cellular homeostasis. Moreover VIRMA is closely linked to the circadian rhythm pathway. It regulates mRNA targets affecting the rhythmic expression of clock genes underlining cellular timing mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com